Doxycycline combats bacterial infections by inhibiting protein synthesis. Specifically, it targets the bacterial ribosome, a cellular structure responsible for building proteins. This interference prevents bacteria from producing the proteins necessary for their survival and replication.
Targeting Bacterial Ribosomes
Doxycycline binds to the 30S ribosomal subunit, a component unique to bacteria. This binding blocks the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, halting the addition of amino acids to the growing polypeptide chain. This process, crucial for protein synthesis, is effectively disrupted, leading to bacterial death.
Broad-Spectrum Activity
This mechanism explains doxycycline’s broad-spectrum activity against a wide range of bacteria, including both Gram-positive and Gram-negative organisms. The shared presence of the 30S ribosomal subunit across many bacterial species makes them susceptible to doxycycline’s action. However, the effectiveness varies depending on the bacterial species and the specific resistance mechanisms they possess.
